A nationwide survey of prophylaxis against ophthalmia neonatorum in Turkey

dc.contributor.authorEser, Ilker
dc.contributor.authorBozaci, Meltem
dc.date.accessioned2025-01-27T20:52:24Z
dc.date.available2025-01-27T20:52:24Z
dc.date.issued2009
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractAim: To analyze the current practice of neonatal conjunctivitis (ophthalmia neonatorum) prophylaxis in Turkey. Materials and methods: A standard questionnaire that collected information regarding the name and location of the clinical setting, the name and dosage of the medication used to prevent neonatal conjunctivitis (if there was any), and the department and preference concerning which health workers should administer the agent (gynecologist, pediatrician, or midwife) was prepared and administered to 24 university hospitals as well as to 24 registered community hospitals that had both pediatric and obstetric units. Results: Neonatal conjunctivitis prophylaxis was administered by 58.3% of the respondents (university hospitals [66.7%] and community hospitals [50%]). The 2 most frequently used substances were gentamycin 18/28 (64.3%) and tobramycin 4/28 (8.3%). Other substances were tetracycline, silver nitrate, povidone-iodine, bacitracin + neomycin, and penicillin G. Conclusion: A nationwide consensus on the clinical department that should be involved, which health workers should administer the agent (gynecologist, pediatrician, or midwife), and which substance should be used for ophthalmia neonatorum prophylaxis must be reached. By using a similar survey other Countries may also assess their Current situation, and decrease the occurrence of neonatal conjunctivitis and neonatal blindness by administering the appropriate substances.
dc.identifier.doi10.3906/sag-0808-23
dc.identifier.endpage774
dc.identifier.issn1300-0144
dc.identifier.issn1303-6165
dc.identifier.issue5
dc.identifier.scopus2-s2.0-70350458731
dc.identifier.scopusqualityQ1
dc.identifier.startpage771
dc.identifier.trdizinid96914
dc.identifier.urihttps://doi.org/10.3906/sag-0808-23
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/96914
dc.identifier.urihttps://hdl.handle.net/20.500.12428/25756
dc.identifier.volume39
dc.identifier.wosWOS:000272499100016
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherTubitak Scientific & Technological Research Council Turkey
dc.relation.ispartofTurkish Journal of Medical Sciences
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20250125
dc.subjectGentamycin
dc.subjectneonatal conjunctivitis
dc.subjectophthalmia neonatorum
dc.subjectpovidone-iodine
dc.subjectprophylaxis
dc.titleA nationwide survey of prophylaxis against ophthalmia neonatorum in Turkey
dc.typeArticle

Dosyalar